1.Scleroderma-Like Condition in Association with the Use of Docetaxel.
Mi Ryung ROH ; Sung Bin CHO ; Kee Yang CHUNG
Annals of Dermatology 2004;16(3):117-119
No abstract available.
2.Leser-Trelat Sign in Glioblastoma Multiforme.
Sung Bin CHO ; Mi Ryung ROH ; Jeanne JUNG ; Se Hoon KIM ; Kee Yang CHUNG
Annals of Dermatology 2005;17(2):62-64
No abstract available.
Glioblastoma*
;
Keratosis, Seborrheic
4.Docetaxel-Induced Onycholysis: The Role of Subungual Hemorrhage and Suppuration.
Mi Ryung ROH ; Jae Yong CHO ; Wook LEW
Yonsei Medical Journal 2007;48(1):124-126
Nail changes are common side effects of taxane chemotherapeutic agents. Docetaxel (Taxotere(R)) is known to cause a great incidence of nail change. Various types of nail changes have previously been reported as a result of treatment with taxanes. We describe 2 cases of severe nail changes induced by docetaxel. The patients had previously been diagnosed with breast cancer and advanced gastric cancer, respectively. During the course of treatment with docetaxel, nail changes became apparent in both patients. Initially, they complained of nail bed purpura. Subungual hematomas with hemopurulent discharge were later observed in several fingers. Drainage of the hemopurulent material occurred spontaneously in our cases, leading to onycholysis. Following drainage, the pain in the nail with subungual hemoprulent material was relieved immediately and spontaneous healing of the patients' nails was noticed after few months. Subungual hemorrhage and suppuration therefore are considered causes of onycholysis and the pain in these patients. Although systemic or topical antibiotics were not used to treat these patients, antibiotics may be also worthwhile to hasten the drainage of the subungual hematomas and suppuration in patients for quick relief of pain.
6.Whole blood cyclosporine measurement by fluorescence polarization immunoassay.
Chan Jung PARK ; Kyung Ryung KANG ; Hyun Chan CHO ; Kyung Hwa LEE ; Hong Rae CHO ; Young Joo LEE ; Yoo Sun KIM ; Eun Mi LEE ; Ki Il PARK
The Journal of the Korean Society for Transplantation 1993;7(1):77-82
No abstract available.
Cyclosporine*
;
Fluorescence Polarization Immunoassay*
;
Fluorescence Polarization*
;
Fluorescence*
7.The Effects of a Sex Education Program on Knowledge Related to Sexually Transmitted Diseases and Sexual Autonomy among University Students.
Yun Hee SHIN ; Young Kyung CHUN ; Sung Mi CHO ; Ye Ryung CHO
Journal of Korean Academy of Nursing 2005;35(7):1304-1313
PURPOSE: The purpose of this study was to evaluate the effects of a sex education program, which was based on the Health Belief Model, on knowledge related to sexually transmitted diseases and sexual autonomy among university students. METHOD: A non-equivalent control group, pretest-posttest design was used. The four session program was delivered to 18 students during 4 weeks; the control group consisted of 23 students. The theme of the first session was "sex, gender, and sexuality: all our concern", "dangerous sex" for the second session, " safe sex" for the third session, and "right sex for you and me" for the fourth session. RESULT: At follow-up, the knowledge related to sexually transmitted diseases and sexual autonomy were significantly greater in the intervention group than in the control group. CONCLUSION: A sex education program with several sessions within the theoretical frame of HBM was effective to improve knowledge related to sexually transmitted diseases and sexual autonomy. The results suggest the potential of a systematic sexual education program to teach healthy sex and to extend the program for other various populations.
Universities
;
Students/*psychology
;
Sexually Transmitted Diseases/*prevention & control
;
*Sexual Behavior
;
*Sex Education
;
Personal Autonomy
;
Male
;
Humans
;
Female
;
Adult
8.Antithrombin III in the Diagnosis and Treatment of Disseminated Intravascular Coagulation in Premature Infants.
Su Jin CHO ; Hye Ryung CHOI ; Young Mi HONG ; Kyung Hee KIM ; Keun LEE ; Eun Ae PARK
Korean Journal of Pediatrics 2004;47(7):740-745
PURPOSE: We evaluated the diagnostic implications and therapeutic efficacy of antithrombin III(AT III) in the disseminated intravascular coagulation(DIC) of premature infants. METHODS: Ninety-two premature infants diagnosed with DIC and treated with AT III from March, 2000 to May, 2003 were retrospectively reviewed. Clinical manifestations, complete blood counts, coagulation tests, and AT III levels were compared between the two groups:definite DIC if clinical signs of DIC and AT III <70% with more than two abnormal laboratory parameters were present, and suspected DIC if not more than two abnormal laboratory parameters were present. RESULTS: AT III was given for an average of 3.2 days and no side effects related to the treatment were reported. The AT III levels increased significantly more than four fold with treatment in both groups. The clinical signs and laboratory values improved significantly after treatment. CONCLUSION: AT III level is a sensitive parameter in the diagnosis of DIC in premature infants, and it is useful as a treatment modality since it improves the clinical symptoms and the laboratory parameters without significant side effects.
Antithrombin III*
;
Blood Cell Count
;
Dacarbazine
;
Diagnosis*
;
Disseminated Intravascular Coagulation*
;
Humans
;
Infant, Newborn
;
Infant, Premature*
;
Retrospective Studies
9.Clinical use of a Sengstaken-Blakemore tube in the management of postpartum hemorrhage.
Pil Je CHO ; Kyung Jin WHANG ; Ji Yeon LEE ; Ho Jin CHOI ; Ho Sun CHANG ; Mi Ryung KIM
Korean Journal of Obstetrics and Gynecology 2007;50(4):594-600
OBJECTIVE: To evaluate the efficacy of clinical use of a intrauterine Sengstaken-Blakemore tube (S-B tube) in postpartum hemorrhage not controlled with medication and conservative treatment. METHODS: Retrospective review was done in 18 women with insertion of S-B tube into intrauterine cavity who did not controlled with medication and conservative treatment for postpartum hemorrhage. After third stage of labor, women were treated with prophylactic intramuscular Methylergonovine 0.2 mg and intravenous infusions of oxytocin routinely. If the postpartum bleeding continued, Misoprostol 800 microgram (per rectal) and intravenous infusions of Dinoprost 2 mg mixed with 5% D/S 500 cc were employed. And then women were examined for retained placenta and laceration of birth canal. Where necessary, retained placenta was removed and lacerations were sutured. If the postpartum bleeding did not controlled despite all of procedures, we decided use of intrauterine S-B tube. RESULTS: The mean age of the patients was 30.9+/-4.4 (27-39) years, their mean body weights and parities were 67.8+/-8.2 (56.2-85.7) kg, 1.8+/-0.8 (1-4) and mean gestational age was 38.5+/-2.9 (37-42) weeks respectively. The mean time from delivery to insertion of S-B tube was 107.6+/-94.0 (24-360) minutes. The mean filled normal saline amount was 190.5+/-35.2 (120-230) cc. Of 18 who was inserted of S B tube, 15 cases needed not additional surgical therapy. So success rate was 83.3%. CONCLUSION: Insertion of intrauterine S-B tube appears as a simple and effective means of treating postpartum hemorrhage not controlled with medication and conservative treatment.
Body Weight
;
Dinoprost
;
Female
;
Gestational Age
;
Hemorrhage
;
Humans
;
Infusions, Intravenous
;
Lacerations
;
Methylergonovine
;
Misoprostol
;
Oxytocin
;
Parturition
;
Placenta, Retained
;
Postpartum Hemorrhage*
;
Postpartum Period*
;
Retrospective Studies
10.Kasabach-Merritt Syndrome Arising from Tufted Angioma Successfully Treated with Systemic Corticosteroid.
Taegyun KIM ; Mi Ryung ROH ; Soohyun CHO ; Kee Yang CHUNG
Annals of Dermatology 2010;22(4):426-430
We report a case of Kasabach-Merritt syndrome arising from a tufted angioma successfully treated with systemic corticosteroid. A 2-month-old male infant presented with a palm-sized, erythematous induration on his left pubis. The lesion was diagnosed as tufted angioma histopathologically. After 1 month, the lesion suddenly expanded to the abdomen and scrotum. Initial laboratory tests were consistent with consumptive coagulopathy. He was diagnosed with Kasabach-Merritt syndrome and treated with intravenous dexamethasone at 0.32 mg/kg/day (equivalent to prednisolone 2.0 mg/kg/day). Two days after initiating the treatment, his platelet counts recovered and the lesion ceased to expand. Steroid therapy was converted to oral prednisolone and the dosage was subsequently tapered, and the lesion gradually involuted with no signs of recurrence for a year.
Abdomen
;
Dexamethasone
;
Hemangioma
;
Humans
;
Infant
;
Kasabach-Merritt Syndrome
;
Male
;
Platelet Count
;
Prednisolone
;
Recurrence
;
Scrotum
;
Skin Neoplasms